Key facts
- This page summarizes Susannah Gray's Form 4 filing for Theravance Biopharma, Inc. (TBPH).
- 4 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 28 Feb 2023, 19:17.
Susannah Gray - 26 Feb 2023 Form 4 Insider Report for Theravance Biopharma, Inc. (TBPH)
- Reporting relationship
- Director
- Issuer ticker
- TBPH
- Reported as of
- 26 Feb 2023
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 28 Feb 2023, 19:17:32 UTC
- Prior SEC filing
- 10 Jun 2022
- Next SEC filing
- 04 May 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Brett A. Grimaud, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Susannah Gray filed Form 4 for Theravance Biopharma, Inc. (TBPH) on 28 Feb 2023.
Change
- Previous filing in this sequence was filed on 10 Jun 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
TBPH
transaction
Ordinary Shares
Award
- Transaction value
- $0
- Shares
- +10,131
- Change %
- Price
- $0.000000
- Shares after
- 10,131
- Date
- 26 Feb 2023
- Ownership
- Direct
TBPH
transaction
Ordinary Shares
Award
- Transaction value
- $0
- Shares
- +1,688
- Change %
- +17%
- Price
- $0.000000
- Shares after
- 11,819
- Date
- 26 Feb 2023
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
TBPH
transaction
Derivative
Share Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +28,000
- Change %
- Price
- $0.000000
- Shares after
- 28,000
- Date
- 26 Feb 2023
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 28,000
- Exercise price
- $9.87
- Footnotes
- F1
TBPH
transaction
Derivative
Share Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +4,666
- Change %
- Price
- $0.000000
- Shares after
- 4,666
- Date
- 26 Feb 2023
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 4,666
- Exercise price
- $9.87
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
The option vests monthly over 24 months of service from the date of grant.
Footnote F2
This option shall vest monthly over two months of service from the date of grant and will vest in full upon earlier of the two-month anniversary of Susannah Gray's appointment to the Board or the date of Company's 2023 annual meeting of Shareholders.